Hefei Hengxin Life Science and Technology Co., Ltd. (SHE:301501)
China · Delayed Price · Currency is CNY 28.00
+0.31 (1.12%)
Jul 31, 2026, 3:04 PM CST
SHE:301501 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 304.46 | 321.14 | 295.71 | 225.31 | 265.55 | 132.37 |
Trading Asset Securities | 318.26 | 368.43 | - | - | - | 0.02 |
Cash & Short-Term Investments | 622.72 | 689.58 | 295.71 | 225.31 | 265.55 | 132.39 |
Cash Growth | -45.20% | 133.19% | 31.24% | -15.15% | 100.58% | 36.13% |
Accounts Receivable | 159.47 | 180.08 | 172.83 | 158.98 | 104.95 | 67.45 |
Other Receivables | 4.64 | 3.67 | 2.26 | 3.34 | 2.9 | 1.96 |
Receivables | 164.11 | 183.75 | 175.08 | 162.33 | 107.85 | 69.4 |
Inventory | 299.51 | 281.2 | 202.51 | 217.31 | 193 | 144.81 |
Other Current Assets | 56.57 | 58.29 | 43.43 | 38.82 | 24.47 | 16.01 |
Total Current Assets | 1,143 | 1,213 | 716.74 | 643.77 | 590.87 | 362.62 |
Property, Plant & Equipment | 1,432 | 1,421 | 1,140 | 809.34 | 547.69 | 292.59 |
Long-Term Investments | - | 50 | - | - | 2.15 | 7.62 |
Other Intangible Assets | 105.22 | 106.2 | 63.36 | 49.06 | 41.47 | 32.27 |
Long-Term Deferred Tax Assets | 6.72 | 6.25 | 24.77 | 21.36 | 11.2 | 7.58 |
Long-Term Deferred Charges | 23.06 | 24.22 | 7.37 | 8.13 | 7.9 | 8.74 |
Other Long-Term Assets | 89.75 | 33.15 | 32.49 | 40.7 | 12.02 | 21.76 |
Total Assets | 2,800 | 2,854 | 1,985 | 1,572 | 1,213 | 733.19 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 331.97 | 369.24 | 332.09 | 307.19 | 291.03 | 144.19 |
Accrued Expenses | 25.73 | 41.8 | 37.34 | 32.46 | 23.66 | 18.88 |
Short-Term Debt | 80.03 | 100.04 | 259.16 | 95.08 | 75.07 | 12.36 |
Current Portion of Long-Term Debt | 40.4 | 26.66 | 32.42 | - | - | - |
Current Portion of Leases | - | 14.11 | 8.73 | 9.74 | 4.77 | 3.66 |
Current Income Taxes Payable | 7.84 | 8.19 | 9.08 | 11.25 | 11.1 | 5.14 |
Current Unearned Revenue | 7.34 | 8.7 | 9.37 | 7.74 | 8.77 | 7.74 |
Other Current Liabilities | 1.68 | 2.96 | 5.1 | 25.3 | 6.78 | 1.17 |
Total Current Liabilities | 495 | 571.69 | 693.29 | 488.77 | 421.18 | 193.14 |
Long-Term Debt | 72.49 | 67.49 | 94.07 | 110.46 | 74.43 | - |
Long-Term Leases | 3.77 | 6.44 | 12.81 | 25.44 | 19.45 | 19.38 |
Long-Term Unearned Revenue | 33.38 | 32.09 | 25.98 | 19.28 | 8.36 | 2.84 |
Long-Term Deferred Tax Liabilities | - | - | 5.96 | 9.23 | 6.6 | 5.43 |
Other Long-Term Liabilities | - | - | 37.29 | 37.29 | 35.69 | 30.69 |
Total Liabilities | 604.63 | 677.7 | 869.4 | 690.49 | 565.71 | 251.48 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 147.9 | 147.9 | 76.5 | 76.5 | 76.5 | 76.5 |
Additional Paid-In Capital | 1,152 | 1,152 | 345.57 | 345.57 | 346.72 | 346.51 |
Retained Earnings | 824.47 | 792.17 | 619.33 | 399.44 | 185.58 | 38.11 |
Comprehensive Income & Other | -3.32 | 13.26 | 5.06 | - | - | - |
Total Common Equity | 2,121 | 2,105 | 1,046 | 821.51 | 608.8 | 461.13 |
Minority Interest | 74.32 | 71.2 | 68.68 | 60.36 | 38.78 | 20.58 |
Shareholders' Equity | 2,195 | 2,176 | 1,115 | 881.87 | 647.57 | 481.71 |
Total Liabilities & Equity | 2,800 | 2,854 | 1,985 | 1,572 | 1,213 | 733.19 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 196.68 | 214.74 | 407.2 | 240.73 | 173.72 | 35.4 |
Net Cash (Debt) | 426.04 | 474.83 | -111.48 | -15.42 | 91.83 | 96.99 |
Net Cash Growth | -43.93% | - | - | - | -5.32% | 55.88% |
Net Cash Per Share | 3.02 | 3.42 | -1.01 | -0.14 | 0.83 | 0.93 |
Filing Date Shares Outstanding | 147.9 | 147.9 | 110.93 | 110.93 | 110.8 | 110.93 |
Total Common Shares Outstanding | 147.9 | 147.9 | 110.93 | 110.93 | 110.8 | 110.93 |
Working Capital | 647.91 | 641.13 | 23.46 | 154.99 | 169.69 | 169.48 |
Book Value Per Share | 14.34 | 14.23 | 9.43 | 7.41 | 5.49 | 4.16 |
Tangible Book Value | 2,016 | 1,999 | 983.1 | 772.45 | 567.33 | 428.85 |
Tangible Book Value Per Share | 13.63 | 13.52 | 8.86 | 6.96 | 5.12 | 3.87 |
Land | - | 21.2 | 19.22 | - | - | - |
Buildings | - | 671.39 | 466.23 | 197.48 | 113.4 | 107.01 |
Machinery | - | 829.27 | 607.87 | 428.1 | 300.04 | 231 |
Construction In Progress | - | 201.07 | 259.59 | 319.72 | 246.9 | 39.59 |